Unlike the scenario concerning cytotoxic drugs and EGFR inhibitors, it remains unknown whether a patient’s HPV infection status affects the efficacy of immune checkpoint inhibitors for SCCHN. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.